Amundi Amarin Corp Plcuk Transaction History

Amundi

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.07 - $1.34 $10,845 - $13,582	10,136 Added 2.53%	410,854 $497,000
Q3 2022 Nov 14, 2022	BUY	$1.09 - $1.67 $851 - $1,304	781 Added 0.2%	400,718 $477,000
Q2 2022 Aug 15, 2022	BUY	$1.13 - $3.69 $451,928 - $1.48 Million	399,937 New	399,937 $568,000
Q1 2022 May 16, 2022	SELL	$2.85 - $3.73 $339,828 - $444,757	-119,238 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.24 - $5.18 $386,331 - $617,652	119,238 New	119,238 $414,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $177M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

Stay updated on Amundi with notifications on news.